# US 2019/0094234 A1 · Kit for predicting implantation success in assisted fertilization

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0094234 A1
- Document ID: US20190094234A1
- Status: Published application
- Kind: A1
- Application number: 16/201,184
- Filed: 2018-11-27
- Published: 2019-03-28
- Earliest claimed: 2006-07-21
- Assignees: Femalon S.P.R.L.
- Applicants: Femalon S.P.R.L.
- Inventors: Nathalie Ledee; Marie-Pierre Piccinni
- Web page: https://patentgrep.com/patent/US20190094234A1

## CPC

- G01N 33/689: {related to pregnancy or the gonads}
- C12Q 1/6876: Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q 1/6883: for diseases caused by alterations of genetic material
- G01N 33/6863: {Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors}
- C12Q 2600/106: Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
- C12Q 2600/158: Expression markers
- G01N 2333/535: Granulocyte CSF; Granulocyte-macrophage CSF
- G01N 2800/367: Infertility, e.g. sperm disorder, ovulatory dysfunction
- G01N 2800/52: Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

A method of obtaining a class of embryos having a higher implantation potential than from morphology selection alone by selecting from multiple embryos, obtained by fertilizing the plurality of oocytes, a class of embryos having a high implantation potential. The selection is determined from a level of granulocyte-colony stimulating factor (G-CSF) present in the follicular fluid (FF) of each oocyte in the multiple oocytes.

## Claims

### Claim 1

A method of assisted fertilization, comprising:
implanting in a subject an embryo, selected from a plurality of embryos obtained by fertilization of a plurality of oocytes collected from the subject, wherein
at least the oocyte having a highest implantation potential of the plurality is implanted as an embryo, and
the implantation potential is determined from a level of granulocyte-colony stimulating factor (G-CSF) present in the follicular fluid (FF) of each oocyte in the plurality of oocytes.

### Claim 2 (depends on 1)

The method of claim 1, wherein the level of granulocyte-colony stimulating factor (G-CSF) present in the follicular fluid (FF) of each oocyte in the plurality of oocytes is determined by radio-immunoassay (RIA), enzyme-linked immunosorbent assay (ELISA) or enzyme-linked immunosorbent spot (ELISPOT) assay, surface plasmon resonance, fluorescence resonance energy transfer, bioluminescence resonance energy transfer, fluorescence quenching fluorescence, fluorescence polarization, mass spectrometry (MS), high performance liquid chromatography (HPLC), HPLC/MS, HPLC/MS/MS, capillary electrophoresis, rod or slab gel electrophoresis.

### Claim 3 (depends on 1)

The method of claim 1, wherein the oocyte embryo having the highest implantation potential has a level of G-CSF present in the FF which is equal to or greater than 24.0 pg/ml.

### Claim 4 (depends on 1)

The method of claim 1, wherein said oocyte having a highest implantation potential has a level of G-CSF present in the FF which is greater than 35.0 pg/ml.
